cdmo capacity planning

cdmo capacity planning

Seven CDMOs Slash Capacity Hits with Semaglutide

Seven CDMOs Slash Capacity Hits with Semaglutide Seven CDMOs are cutting capacity bottlenecks for semaglutide by shifting to continuous flow platforms, strategic outsourcing, and data-driven planning. By 2035, demand for semaglutide and tirzepatide APIs is projected to surge six-fold, a jump that will rewrite the rules of scaling for CDMOs.